These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1963 related items for PubMed ID: 30409172

  • 21. Systematic characterization of a non-transgenic Aβ1-42 amyloidosis model: synaptic plasticity and memory deficits in female and male mice.
    Jiménez-Herrera R, Contreras A, Djebari S, Mulero-Franco J, Iborra-Lázaro G, Jeremic D, Navarro-López J, Jiménez-Díaz L.
    Biol Sex Differ; 2023 Sep 16; 14(1):59. PubMed ID: 37716988
    [Abstract] [Full Text] [Related]

  • 22. Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity.
    Welzel AT, Maggio JE, Shankar GM, Walker DE, Ostaszewski BL, Li S, Klyubin I, Rowan MJ, Seubert P, Walsh DM, Selkoe DJ.
    Biochemistry; 2014 Jun 24; 53(24):3908-21. PubMed ID: 24840308
    [Abstract] [Full Text] [Related]

  • 23. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E, Taylor K, Bilousova T, Weiland D, Pham T, Zuo X, Yang F, Chen PP, Glabe CG, Takacs A, Hoffman DR, Frautschy SA, Cole GM.
    Neurobiol Dis; 2015 Oct 24; 82():552-560. PubMed ID: 26369878
    [Abstract] [Full Text] [Related]

  • 24. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    Yang T, Li S, Xu H, Walsh DM, Selkoe DJ.
    J Neurosci; 2017 Jan 04; 37(1):152-163. PubMed ID: 28053038
    [Abstract] [Full Text] [Related]

  • 25. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A, Capetillo-Zarate E, Kosterin I, Abramowski D, Kumar S, Yamaguchi H, Walter J, Fändrich M, Staufenbiel M, Thal DR.
    Neurobiol Aging; 2012 Nov 04; 33(11):2641-60. PubMed ID: 22305478
    [Abstract] [Full Text] [Related]

  • 26. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C, Inestrosa NC.
    J Neurochem; 2018 Feb 04; 144(4):443-465. PubMed ID: 29240990
    [Abstract] [Full Text] [Related]

  • 27. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G, Liu HL, Zhang H, Tong XJ.
    Neuroscience; 2015 Jul 09; 298():357-66. PubMed ID: 25917310
    [Abstract] [Full Text] [Related]

  • 28. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J, Lefort R, Shelanski ML.
    Neuroscience; 2013 Oct 22; 251():51-65. PubMed ID: 22687952
    [Abstract] [Full Text] [Related]

  • 29. Simvastatin treatment preserves synaptic plasticity in AβPPswe/PS1dE9 mice.
    Métais C, Brennan K, Mably AJ, Scott M, Walsh DM, Herron CE.
    J Alzheimers Dis; 2014 Oct 22; 39(2):315-29. PubMed ID: 24164738
    [Abstract] [Full Text] [Related]

  • 30. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X, Hu X, Yang Y, Takata T, Sakurai T.
    Exp Neurol; 2015 Sep 22; 271():145-54. PubMed ID: 26057947
    [Abstract] [Full Text] [Related]

  • 31. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
    Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL.
    J Neurosci; 2004 Nov 10; 24(45):10191-200. PubMed ID: 15537891
    [Abstract] [Full Text] [Related]

  • 32. Alzheimer's disease.
    De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.
    Subcell Biochem; 2012 Nov 10; 65():329-52. PubMed ID: 23225010
    [Abstract] [Full Text] [Related]

  • 33. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP).
    Rammes G, Seeser F, Mattusch K, Zhu K, Haas L, Kummer M, Heneka M, Herms J, Parsons CG.
    Neuropharmacology; 2018 Sep 15; 140():184-192. PubMed ID: 30016667
    [Abstract] [Full Text] [Related]

  • 34. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
    Kimura R, MacTavish D, Yang J, Westaway D, Jhamandas JH.
    Mol Neurobiol; 2017 Jan 15; 54(1):748-754. PubMed ID: 26768593
    [Abstract] [Full Text] [Related]

  • 35. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
    Wu M, Shi H, He Y, Yuan L, Qu X, Zhang J, Wang Z, Cai H, Qi J.
    J Alzheimers Dis; 2017 Jan 15; 59(3):1067-1078. PubMed ID: 28731445
    [Abstract] [Full Text] [Related]

  • 36. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
    Huang S, Tong H, Lei M, Zhou M, Guo W, Li G, Tang X, Li Z, Mo M, Zhang X, Chen X, Cen L, Wei L, Xiao Y, Li K, Huang Q, Yang X, Liu W, Zhang L, Qu S, Li S, Xu P.
    Brain Res; 2018 Jan 01; 1678():129-137. PubMed ID: 29066369
    [Abstract] [Full Text] [Related]

  • 37. N-truncated Aβ4-x peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse models.
    Wirths O, Walter S, Kraus I, Klafki HW, Stazi M, Oberstein TJ, Ghiso J, Wiltfang J, Bayer TA, Weggen S.
    Alzheimers Res Ther; 2017 Oct 04; 9(1):80. PubMed ID: 28978359
    [Abstract] [Full Text] [Related]

  • 38. Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease.
    Tan VTY, Mockett BG, Ohline SM, Parfitt KD, Wicky HE, Peppercorn K, Schoderboeck L, Yahaya MFB, Tate WP, Hughes SM, Abraham WC.
    Mol Brain; 2018 Feb 09; 11(1):7. PubMed ID: 29426354
    [Abstract] [Full Text] [Related]

  • 39. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM.
    Nature; 2009 Feb 26; 457(7233):1128-32. PubMed ID: 19242475
    [Abstract] [Full Text] [Related]

  • 40. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ, Xu J, Zeng C, Kirk MJ, Mozzoni K, Silky C, Rehak C, Yurko R, Look G, Rishton G, Safferstein H, Cruchaga C, Goate A, Cahill MA, Arancio O, Mach RH, Craven R, Head E, LeVine H, Spires-Jones TL, Catalano SM.
    PLoS One; 2014 Feb 26; 9(11):e111899. PubMed ID: 25390692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 99.